Loading…

Viatris Inc (VTRS) Stock Analysis | GoodMoat

VTRS

VTRS

Viatris Inc

NASDAQ · Stock Profile · Market Cap $15.83B

Current Price

$13.74

-0.43%

GoodMoat Value

$48.30

251.5% undervalued

P/E-4.50

EPS$-3.00

Beta—

P/B1.09

EV/EBITDA—

Div Yield3.49%

Did you know?

Capital expenditures increased by 300% from FY25 to FY25.

VTRS Price Chart

Market Cap$15.83B

Current Price$13.74

P/E Ratio-4.50

Forward P/E—

PEG Ratio0.15

EPS$-3.00

Book Value$12.57

P/B Ratio1.09

FCF vs CAPEX

Forward estimates use 35.3% FCF growth (CAGR)

Cash vs Debt

Net Debt: 13.1B

Revenue

3.8B

FY24

3.8B

FY24

14.7B

FY24

3.3B

FY25

3.6B

FY25

3.8B

FY25

14.3B

FY25

Net Income

—

FY24

95M

FY24

—

FY24

—

FY25

—

FY25

—

FY25

—

FY25

About

Viatris Inc

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

Pennsylvania, USA

52-Week Range

$6.94

$16.00

50-Day MA: $14.08200-Day MA: $10.94

Did you know?

VTRS's revenue grew at a 24.7% CAGR over the last 6 years.